Amgen Inc (AMGN)
269.72
+0.34
(+0.13%)
USD |
NASDAQ |
Apr 26, 11:38
Amgen Price: 269.72 for April 26, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 25, 2024 | 273.45 | 274.35 | 267.24 | 269.38 | 1.760M |
| Apr 24, 2024 | 270.63 | 274.86 | 269.64 | 273.01 | 2.467M |
| Apr 23, 2024 | 272.14 | 274.48 | 271.05 | 273.54 | 2.493M |
| Apr 22, 2024 | 269.84 | 273.14 | 269.84 | 271.91 | 2.166M |
| Apr 19, 2024 | 264.63 | 269.38 | 260.68 | 268.93 | 3.380M |
| Apr 18, 2024 | 265.64 | 265.92 | 262.58 | 262.75 | 2.083M |
| Apr 17, 2024 | 267.54 | 268.78 | 263.38 | 264.07 | 2.175M |
| Apr 16, 2024 | 266.83 | 267.51 | 263.81 | 265.64 | 2.018M |
| Apr 15, 2024 | 269.93 | 270.93 | 264.34 | 265.51 | 1.740M |
| Apr 12, 2024 | 268.77 | 269.30 | 266.16 | 267.28 | 2.140M |
| Apr 11, 2024 | 270.22 | 273.00 | 268.44 | 270.00 | 2.170M |
| Apr 10, 2024 | 267.96 | 268.38 | 264.63 | 266.45 | 1.950M |
| Apr 09, 2024 | 270.19 | 271.29 | 268.58 | 270.36 | 1.793M |
| Apr 08, 2024 | 269.48 | 270.21 | 267.56 | 269.20 | 1.831M |
| Apr 05, 2024 | 265.90 | 273.07 | 265.08 | 269.95 | 2.294M |
| Apr 04, 2024 | 276.05 | 276.73 | 267.75 | 268.09 | 2.451M |
| Apr 03, 2024 | 275.69 | 276.47 | 273.68 | 274.42 | 1.669M |
| Apr 02, 2024 | 283.34 | 283.91 | 276.04 | 276.21 | 2.221M |
| Apr 01, 2024 | 282.11 | 283.83 | 279.00 | 283.04 | 1.869M |
| Mar 28, 2024 | 287.86 | 288.56 | 284.21 | 284.32 | 2.290M |
| Mar 27, 2024 | 284.22 | 286.82 | 282.55 | 286.30 | 2.256M |
| Mar 26, 2024 | 282.15 | 284.50 | 280.70 | 281.77 | 3.343M |
| Mar 25, 2024 | 276.43 | 281.33 | 275.41 | 280.82 | 2.954M |
| Mar 22, 2024 | 277.39 | 278.29 | 275.10 | 276.17 | 2.303M |
| Mar 21, 2024 | 274.63 | 277.92 | 274.39 | 276.95 | 2.490M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
166.70
Minimum
May 31 2019
324.56
Maximum
Feb 01 2024
237.06
Average
236.80
Median
Price Benchmarks
| Gilead Sciences Inc | 65.62 |
| Johnson & Johnson | 146.63 |
| Eli Lilly and Co | 736.41 |
| Merck & Co Inc | 131.35 |
| Vertex Pharmaceuticals Inc | 398.65 |
Price Related Metrics
| PE Ratio | 21.59 |
| PS Ratio | 5.145 |
| PEG Ratio | 6.882 |
| Price to Book Value | 23.19 |
| Price to Free Cash Flow | 19.71 |
| Earnings Yield | 4.63% |
| Market Cap | 144.55B |
| PEGY Ratio | 3.403 |
| Operating PE Ratio | 18.37 |
| Normalized PE Ratio | 21.59 |